A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer

Seminars in Oncology

Volumn 24, Issue 3 SUPPL. 8, 1997, Pages

  Manegold, C ^a   Drings, P ^a   Von Pawel, J ^a   Ricci, S ^a   Dornoff, W ^a   Van Walree, N ^a   Ten Bokkel Huinink, W ^a   Chemaissani, A ^a   Stahel, P ^a   Bergman, B ^a   Wagenius, G ^a   Sederholm, C ^a   Mattson, K ^a   Liippo, K ^a   Kellokumpu Lehtinen, P ^a  

^a Thoraxklinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CISPLATIN; DEOXYCYTIDINE; DRUG DERIVATIVE; ETOPOSIDE; RIBONUCLEOTIDE REDUCTASE;

ALOPECIA; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING; ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG ANTAGONISM; LUNG TUMOR; METASTASIS; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ALOPECIA; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NAUSEA; NEOPLASM METASTASIS; RIBONUCLEOTIDE REDUCTASES; TREATMENT OUTCOME; VOMITING;

EID: 0030975842     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)